Evidence map›Paper›PMID 39665084›Full record

ArticleJournal of biomedical optics2024

Measurement of tissue optical properties in the 400 to 700 nm range to assess light penetration depths for laser treatment of upper tract urothelial carcinomas.

Himemi Watabe, Yu Shimojo, Asako Shingu, Hidenori Ito, Hideo Fukuhara, Makito Miyake, Keiji Inoue, Kiyohide Fujimoto, Takahiro Nishimura

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Himemi WatabeOsaka University, Graduate School of Engineering, Osaka, Japan.
Yu ShimojoOsaka University, Graduate School of Engineering, Osaka, Japan.
Asako ShinguSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Hidenori ItoSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Hideo FukuharaKochi Medical School, Department of Urology, Kochi, Japan.
Makito MiyakeNara Medical University, Department of Urology, Nara, Japan.
Keiji InoueKochi Medical School, Department of Urology, Kochi, Japan.
Kiyohide FujimotoNara Medical University, Department of Urology, Nara, Japan.
Takahiro NishimuraOsaka University, Graduate School of Engineering, Osaka, Japan.ORCID 0000-0001-6549-0694

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: For therapeutic approaches for upper tract urothelial carcinomas, the absorption Aim: The Approach: The optical properties were determined with a double integrating sphere optical system and inverse Monte Carlo methods. Results: Conclusion: Optical properties of human and porcine upper urinary tracts provide insights into light distributions and the validity of

Indexed as

Laser TherapyAdipose TissueAnimalsHumansKidney NeoplasmsKidney PelvisMonte Carlo MethodScattering, RadiationSwineUreterUreteral NeoplasmsUrotheliumhuman tissuelaser treatmentlight penetration depthoptical propertiesupper tract urothelial carcinomaupper urinary tract

Identifiers

PMID39665084
PMCPMC11629118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.